Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer
Status:
Terminated
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Epoetin alfa may cause the body to make more red blood cells. It is used to treat
anemia caused by cancer and chemotherapy. It may also help relieve fatigue in patients with
anemia.
PURPOSE: This randomized clinical trial is studying how well epoetin alfa works in treating
patients with anemia who are undergoing chemotherapy for cancer.